Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective, Observational Molecular Epidemiology Study of HER2 Expression in Patients With Early / Metastatic Breast Cancer in Saudi Arabia

NCT02954471 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02954471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02954471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective, Observational Molecular Epidemiology Study of HER2 Expression in Patients With Early / Metastatic Breast Cancer in Saudi Arabia
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
October 21, 2016
Completion date
September 17, 2019
Enrollment
351 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer